Revenue
2022
2023
2024
ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
Price—Loading quote
Net income
2022
2023
2024
Free cash flow
2022
2023
2024
Total cash / debt
CashTotal debt
2021
2022
2023
2024
Financial statements
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Revenue | ¥980.6M | ¥222.0M | ¥209.7M |
| Gross profit | ¥951.6M | ¥191.4M | ¥187.7M |
| Research & development | ¥947.2M | ¥707.0M | ¥743.1M |
| Net income | −¥405.4M | −¥925.6M | −¥882.9M |
| Basic EPSper diluted share | -CN¥1.34 | -CN¥3.28 | -CN¥3.35 |
| Diluted EPSper diluted share | -CN¥1.34 | -CN¥3.28 | -CN¥3.35 |